129 related articles for article (PubMed ID: 23394726)
41. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
42. Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
Roberts JN; Graham BS; Karron RA; Munoz FM; Falsey AR; Anderson LJ; Marshall V; Kim S; Beeler JA
Vaccine; 2016 Sep; 34(41):4843-4849. PubMed ID: 27566900
[TBL] [Abstract][Full Text] [Related]
43. Updates from the 18th National Immunization Conference for Health Care Workers: Manchester Conference Centre, December 2007.
Guppy MJ; Baxter DN
Hum Vaccin; 2009 May; 5(5):284-90. PubMed ID: 19077537
[TBL] [Abstract][Full Text] [Related]
44. Gene Based Vaccines: Optimising Development and Delivery - A marcus evans Conference.
Garren H
IDrugs; 2010 Nov; 13(11):759-61. PubMed ID: 21046520
[TBL] [Abstract][Full Text] [Related]
45. Universal influenza vaccines: Shifting to better vaccines.
Berlanda Scorza F; Tsvetnitsky V; Donnelly JJ
Vaccine; 2016 Jun; 34(26):2926-2933. PubMed ID: 27038130
[TBL] [Abstract][Full Text] [Related]
46. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
47. Adjuvanted influenza vaccines.
Even-Or O; Samira S; Ellis R; Kedar E; Barenholz Y
Expert Rev Vaccines; 2013 Sep; 12(9):1095-108. PubMed ID: 24053401
[TBL] [Abstract][Full Text] [Related]
48. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
International Liaison Committee on Resuscitation
Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
[TBL] [Abstract][Full Text] [Related]
49. Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.
Robinson L; Knight-Jones TJ; Charleston B; Rodriguez LL; Gay CG; Sumption KJ; Vosloo W
Transbound Emerg Dis; 2016 Jun; 63 Suppl 1():30-41. PubMed ID: 27320164
[TBL] [Abstract][Full Text] [Related]
50. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches.
Negahdaripour M; Eslami M; Nezafat N; Hajighahramani N; Ghoshoon MB; Shoolian E; Dehshahri A; Erfani N; Morowvat MH; Ghasemi Y
Infect Genet Evol; 2017 Oct; 54():402-416. PubMed ID: 28780192
[TBL] [Abstract][Full Text] [Related]
51. Current status and progress of prepandemic and pandemic influenza vaccine development.
Leroux-Roels I; Leroux-Roels G
Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
[TBL] [Abstract][Full Text] [Related]
52. Conference report: Bioanalysis highlights from the 2012 American Association of Pharmaceutical Scientists National Biotechnology Conference.
Crisino RM; Geist B; Li J
Bioanalysis; 2012 Sep; 4(17):2103-7. PubMed ID: 23013391
[TBL] [Abstract][Full Text] [Related]
53. The new H1N1 and HPV vaccines and old fears.
Balofsky A; Agmon-Levin N; Shoenfeld Y
Curr Opin Rheumatol; 2010 Jul; 22(4):431-6. PubMed ID: 20485175
[TBL] [Abstract][Full Text] [Related]
54. Integration of Novel Materials and Advanced Genomic Technologies into New Vaccine Design.
Liao W; Zhang TT; Gao L; Lee SS; Xu J; Zhang H; Yang Z; Liu Z; Li W
Curr Top Med Chem; 2017; 17(20):2286-2301. PubMed ID: 28240182
[TBL] [Abstract][Full Text] [Related]
55. Rotavirus vaccines against diarrhoeal disease.
Vesikari T
Lancet; 1997 Nov; 350(9090):1538-41. PubMed ID: 9388411
[TBL] [Abstract][Full Text] [Related]
56. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
57. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
[TBL] [Abstract][Full Text] [Related]
58. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
59. Malaria vaccine.
Khurana SK; Talib VH
Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
[TBL] [Abstract][Full Text] [Related]
60. Up to date: comprehensive knowledge of human papillomavirus.
Park JS; Hur S
Expert Rev Vaccines; 2013 Apr; 12(4):353-5. PubMed ID: 23560916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
